Prostate Cancer UK Grants $355K to University of Birmingham for Development of New Test

Prostate Cancer UK Grants $355K to University of Birmingham for Development of New Test
Prostate Cancer UK has awarded more than $355,000 (£275,000) to University of Birmingham researchers to develop a diagnostic tool that can measure the aggressiveness of a patient's prostate cancer. The new technology will help physicians identify the best course of treatment for each patient. The grant is part of Prostate Cancer UK’s nearly $3.9 million (£3 million) Research Innovation Awards initiative, which encourages scientists across the U.K. to develop innovative and ambitious research aimed at helping to fight the disease. There is no test currently that can measure how aggressive a prostate tumor will be, so when prescribing a therapy, doctors have no way of knowing if the chosen course of treatment is the best for a particular patient. “Prostate specific antigen, or PSA, is produced naturally by the prostate. A raised level in the blood can indicate a problem, but this doesn’t always mean cancer," project leader Paula Mendes, PhD, a professor in the University of Birmingham's School of Chemical Engineering, said in a press release. She explained that her research is now focusing on the use of colored nanoparticles that distinguish between PSA molecules coming from healthy prostate cells and those that are being produced by the tumor cells, allowing researchers to determine how aggressive a c
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *